IMR Press / FBL / Volume 11 / Issue 3 / DOI: 10.2741/1981

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Cellular immunology in HIV-1 positive African American women using alcohol and cocaine
Show Less
1 Division of Oral Biology & Medicine, UCLA School of Dentistry, Los Angeles, CA 90095-1668, West-Los Angeles, Veterans Administration Medical Center, Los Angeles, CA 90025
2 Comprehensive Drmicrogram Research Center, University of Miami Miller School of Medicine, Miami, FL 33136
3 Departments of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136
4 Departments of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136
5 Departments of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136
6 Departments of Epidemiology, University of Miami Miller School of Medicine, Miami, FL 33136
7 Department of Anthropology, University of Miami, Coral Gables, Florida 33124
Front. Biosci. (Landmark Ed) 2006, 11(3), 2434–2441; https://doi.org/10.2741/1981
Published: 1 September 2006
Abstract

Co-use of illicit drugs, in particular cocaine and alcohol, is common among HIV-1+ men and women of different ethnic groups. We compared cohorts of alcohol and cocaine co-users HIV-1+ African American women and in cohorts of drug-free, or methamphetamine users HIV-1+ men. We monitored clinical cellular immune parameters at repeated regular intervals. We found that significant inverse correlations between CD8+CD38+ cells and subpopulations of CD4+ cells distinguished by the expression of CD45RA in HIV-1+ alcohol and cocaine co- users but not in drug-free HIV-1+ patients. Following stratification for CD4+ cell number, we found the CD4+CD45RA+ subpopulation to be significantly higher (p < 0.05) in the drug user compared to drug-free HIV-1+. Drug abuse may alter the change from the CD4+CD45RA+ to the CD4+CD45RA- phenotype selectively, which recovers in HIV-1+ methamphetamine abusers during treatment from baseline to 4-weeks, as manifested by improved IL-2 production in vitro. of TH1 and TH2 cytokines during progression to AIDS.

Keywords
Cocaine
Cocaethylene
Methamphetamine
immunopathology
HIV-1 seropositive
CD4+
CD45RA+
CD4+CD45RA
Phenotype
Share
Back to top